Literature DB >> 11516235

Is infection a major risk factor for preeclampsia?

J A Herrera1, G Chaudhuri, P López-Jaramillo.   

Abstract

Recently in an open population-based program composed of 15 354 pregnant women in Colombia we applied a biopsychosocial risk model, which permitted us to identify pregnant women at high risk of preeclampsia. 1443 (9.4%) of patients at high risk for developing preeclampsia received 450 mg of linoleic acid, and 1.5 g/day of calcium. Bacteriuria was identified in 1766 (11.5%) and vaginal infections in 2150 (14.0%) of the pregnant women. These women received oral antibiotics for 10 days. The incidence of low birthweight, preterm delivery and preeclampsia were reduced by 53% (6.2% vs 13.2%), 64.7% (1.8% vs 5.1%), and 52.5% (3.8% vs 8.0%) respectively, when compared with the incidence of the preceding five years. We believe that these dramatic reductions were due to early identification of risk factors, administration of nutritional supplements and principally by treatment of asymptomatic infections. Unfortunately, because of the study design it is not possible to confirm that infection was the major risk factor for preeclampsia in our population. However, we hypothesize that chronic subclinical infections may cause increased maternal cytokine levels sufficient to affect vascular endothelial function, and so prime individuals for the subsequent development of preeclampsia. This hypothesis can be tested in a more appropriately designed clinical trial to assess whether there is a relationship between infection, inflammation and preeclampsia. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516235     DOI: 10.1054/mehy.2001.1378

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  25 in total

1.  Inflammatory responses to trivalent influenza virus vaccine among pregnant women.

Authors:  Lisa M Christian; Jay D Iams; Kyle Porter; Ronald Glaser
Journal:  Vaccine       Date:  2011-09-22       Impact factor: 3.641

2.  Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.

Authors:  Te-Yao Hsu; Jyun-Mu Lin; Mai-Huong T Nguyen; Feng-Hsiang Chung; Ching-Chang Tsai; Hsin-Hsin Cheng; Yun-Ju Lai; Hsuan-Ning Hung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2017-12-28       Impact factor: 5.911

3.  Severe preeclampsia and maternal self-report of oral health, hygiene, and dental care.

Authors:  Kim A Boggess; Erica K Berggren; Viktoria Koskenoja; Diana Urlaub; Carol Lorenz
Journal:  J Periodontol       Date:  2012-04-17       Impact factor: 6.993

4.  Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth.

Authors:  Wouter J den Hollander; Sarah Schalekamp-Timmermans; I Lisanne Holster; Vincent W Jaddoe; Albert Hofman; Henriëtte A Moll; Guillermo I Perez-Perez; Martin J Blaser; Eric A P Steegers; Ernst J Kuipers
Journal:  Helicobacter       Date:  2016-10-27       Impact factor: 5.753

Review 5.  Human infectious diseases and risk of preeclampsia: an updated review of the literature.

Authors:  Malihe Nourollahpour Shiadeh; Zahra Behboodi Moghadam; Ishag Adam; Vafa Saber; Maryam Bagheri; Ali Rostami
Journal:  Infection       Date:  2017-06-02       Impact factor: 3.553

Review 6.  Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies.

Authors:  Luis O Rustveld; Sheryl F Kelsey; Ravi Sharma
Journal:  Matern Child Health J       Date:  2007-06-19

7.  Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection.

Authors:  T Todros; P Verdiglione; G Oggè; D Paladini; P Vergani; S Cardaropoli
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

8.  Is there any difference between preeclamptic and healthy pregnant women regarding the presence of periopathogenic bacteria in the placenta?

Authors:  Fateme Mostajeran; Bahareh Arbabi
Journal:  Int J Prev Med       Date:  2013-03

9.  Clinical trial to assess the effect of physical exercise on endothelial function and insulin resistance in pregnant women.

Authors:  Robinson Ramírez-Vélez; Ana C Aguilar; Mildrey Mosquera; Ronald G Garcia; Laura M Reyes; Patricio López-Jaramillo
Journal:  Trials       Date:  2009-11-17       Impact factor: 2.279

Review 10.  Maternal microbiome in preeclampsia pathophysiology and implications on offspring health.

Authors:  Jeanne A Ishimwe
Journal:  Physiol Rep       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.